ECSP19043725A - Composiciones de aminoácidos y métodos para el tratamiento de enfermedades y trastornos musculares - Google Patents
Composiciones de aminoácidos y métodos para el tratamiento de enfermedades y trastornos muscularesInfo
- Publication number
- ECSP19043725A ECSP19043725A ECSENADI201943725A ECDI201943725A ECSP19043725A EC SP19043725 A ECSP19043725 A EC SP19043725A EC SENADI201943725 A ECSENADI201943725 A EC SENADI201943725A EC DI201943725 A ECDI201943725 A EC DI201943725A EC SP19043725 A ECSP19043725 A EC SP19043725A
- Authority
- EC
- Ecuador
- Prior art keywords
- amino acid
- methods
- disorders
- treatment
- acid compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 150000001413 amino acids Chemical class 0.000 title abstract 2
- 208000021642 Muscular disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000004220 muscle function Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/316—Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente descripción proporciona composiciones que comprenden entidades de aminoácidos. La descripción también proporciona métodos para mejorar función muscular que comprende la administración de una cantidad eficaz de las composiciones a un sujeto que lo necesita.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662436073P | 2016-12-19 | 2016-12-19 | |
US201762443205P | 2017-01-06 | 2017-01-06 | |
US201762491776P | 2017-04-28 | 2017-04-28 | |
US201762545358P | 2017-08-14 | 2017-08-14 | |
US201762576321P | 2017-10-24 | 2017-10-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP19043725A true ECSP19043725A (es) | 2019-07-31 |
Family
ID=61025047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSENADI201943725A ECSP19043725A (es) | 2016-12-19 | 2019-06-19 | Composiciones de aminoácidos y métodos para el tratamiento de enfermedades y trastornos musculares |
Country Status (21)
Country | Link |
---|---|
US (3) | US20180207119A1 (es) |
EP (1) | EP3554493A1 (es) |
JP (1) | JP2020502183A (es) |
KR (1) | KR20190099243A (es) |
CN (1) | CN110267655A (es) |
AU (1) | AU2017379825A1 (es) |
BR (1) | BR112019012476A2 (es) |
CA (1) | CA3046558A1 (es) |
CL (1) | CL2019001685A1 (es) |
CO (1) | CO2019006292A2 (es) |
CU (1) | CU20190057A7 (es) |
EC (1) | ECSP19043725A (es) |
IL (1) | IL267210A (es) |
JO (1) | JOP20190147A1 (es) |
MA (1) | MA50763A (es) |
MX (1) | MX2019007352A (es) |
PE (1) | PE20191206A1 (es) |
PH (1) | PH12019501339A1 (es) |
TW (1) | TWI780096B (es) |
WO (1) | WO2018118957A1 (es) |
ZA (1) | ZA201903581B (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
US11617731B2 (en) | 2017-04-28 | 2023-04-04 | Axcella Health, Inc. | Amino acid compositions and their use for the treatment of traumatic brain injury |
SG11202001131TA (en) * | 2017-08-14 | 2020-03-30 | Axcella Health Inc | Amino acid compositions for the treatment of neuronal injury |
PE20200747A1 (es) | 2017-08-14 | 2020-07-24 | Axcella Health Inc | Composiciones de aminoacidos para el tratamiento de enfermedad hepatica |
AU2019288371A1 (en) | 2018-06-20 | 2020-12-03 | Axcella Health Inc. | Methods of manufacturing amino acid compositions |
MA52971A (fr) | 2018-06-20 | 2021-04-28 | Axcella Health Inc | Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle |
CU20200106A7 (es) | 2018-06-20 | 2021-08-06 | Axcella Health Inc | Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias |
WO2020064692A1 (en) * | 2018-09-27 | 2020-04-02 | Société des Produits Nestlé S.A. | Use of histidine, glycine and other aminoacids for preventing insulin resistance and/or diabetes |
KR102456270B1 (ko) * | 2019-09-24 | 2022-10-19 | 마이오텍사이언스 주식회사 | 비천연 아미노산 유도체를 함유하는 근감소증의 예방 또는 치료용 약학적 조성물 |
KR102338447B1 (ko) * | 2019-09-24 | 2021-12-14 | 마이오텍사이언스 주식회사 | 비천연 아미노산을 함유하는 근감소증의 예방 또는 치료용 약학적 조성물 |
CN110801007A (zh) * | 2019-12-17 | 2020-02-18 | 苟春虎 | 老年肌少症营养肽 |
US20230089723A1 (en) * | 2020-03-06 | 2023-03-23 | Axcella Health Inc. | Amino acid compositions and methods for muscle and myotube modulation |
CN113288890B (zh) * | 2021-06-21 | 2022-02-22 | 南方医科大学南方医院 | N-乙酰-l-半胱氨酸在制备预防和/或治疗运动损伤的药物中的应用 |
WO2024026307A1 (en) | 2022-07-25 | 2024-02-01 | Axcella Health Inc. | Biomarker for long covid and fatigue |
WO2024030909A1 (en) | 2022-08-01 | 2024-02-08 | Axcella Health Inc. | Biomarkers of amino acid composition treatment response in long covid |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001257917A1 (en) * | 2000-02-01 | 2001-08-14 | Muscletech Research And Development Inc. | Alpha lipoic acid based food supplement to increase lean muscle mass and strength |
US20040087490A1 (en) * | 2002-09-20 | 2004-05-06 | Troup John P. | Nutritional compositions |
WO2006009975A2 (en) * | 2004-06-22 | 2006-01-26 | Maxim Pharmaceuticals, Inc. | Histamine to treat disorders affecting muscle function |
WO2006105112A2 (en) * | 2005-03-29 | 2006-10-05 | Ajinomoto Co., Inc. | Amino acid-containing composition for preventing or remedying in the skeletal muscle of aged people |
JP2007023921A (ja) * | 2005-07-19 | 2007-02-01 | Toyota Motor Corp | 内燃機関の制御装置 |
US20070286909A1 (en) * | 2006-06-07 | 2007-12-13 | Daniel S. Smith | Amino acid compositions |
CN100518815C (zh) * | 2007-02-15 | 2009-07-29 | 北京苏里曼医药科技有限公司 | 一种氨基酸组合物 |
CA2845829A1 (en) * | 2011-08-19 | 2013-02-28 | Musclepharm Corporation | Compositions and methods for use in promoting lean body mass |
JP2017501113A (ja) * | 2013-10-23 | 2017-01-12 | ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ | アミノ酸によるmTORC1の調節およびその使用 |
-
2017
- 2017-06-16 JO JOP/2019/0147A patent/JOP20190147A1/ar unknown
- 2017-12-19 CN CN201780078594.XA patent/CN110267655A/zh active Pending
- 2017-12-19 EP EP17835529.3A patent/EP3554493A1/en not_active Withdrawn
- 2017-12-19 KR KR1020197020658A patent/KR20190099243A/ko not_active Application Discontinuation
- 2017-12-19 CA CA3046558A patent/CA3046558A1/en active Pending
- 2017-12-19 AU AU2017379825A patent/AU2017379825A1/en not_active Abandoned
- 2017-12-19 TW TW106144666A patent/TWI780096B/zh not_active IP Right Cessation
- 2017-12-19 BR BR112019012476A patent/BR112019012476A2/pt active Search and Examination
- 2017-12-19 JP JP2019532941A patent/JP2020502183A/ja active Pending
- 2017-12-19 WO PCT/US2017/067368 patent/WO2018118957A1/en active Application Filing
- 2017-12-19 PE PE2019001282A patent/PE20191206A1/es unknown
- 2017-12-19 US US15/847,343 patent/US20180207119A1/en not_active Abandoned
- 2017-12-19 MX MX2019007352A patent/MX2019007352A/es unknown
- 2017-12-19 MA MA050763A patent/MA50763A/fr unknown
- 2017-12-19 CU CU2019000057A patent/CU20190057A7/es unknown
- 2017-12-29 US US15/858,475 patent/US20180169046A1/en not_active Abandoned
- 2017-12-29 US US15/858,605 patent/US20180169047A1/en not_active Abandoned
-
2019
- 2019-06-04 ZA ZA2019/03581A patent/ZA201903581B/en unknown
- 2019-06-10 IL IL267210A patent/IL267210A/en unknown
- 2019-06-13 PH PH12019501339A patent/PH12019501339A1/en unknown
- 2019-06-17 CO CONC2019/0006292A patent/CO2019006292A2/es unknown
- 2019-06-19 CL CL2019001685A patent/CL2019001685A1/es unknown
- 2019-06-19 EC ECSENADI201943725A patent/ECSP19043725A/es unknown
Also Published As
Publication number | Publication date |
---|---|
PH12019501339A1 (en) | 2019-09-30 |
BR112019012476A2 (pt) | 2020-04-14 |
US20180169047A1 (en) | 2018-06-21 |
PE20191206A1 (es) | 2019-09-10 |
AU2017379825A1 (en) | 2019-06-13 |
US20180169046A1 (en) | 2018-06-21 |
CN110267655A (zh) | 2019-09-20 |
IL267210A (en) | 2019-08-29 |
KR20190099243A (ko) | 2019-08-26 |
CO2019006292A2 (es) | 2019-06-28 |
WO2018118957A1 (en) | 2018-06-28 |
JOP20190147A1 (ar) | 2019-06-18 |
TW201827068A (zh) | 2018-08-01 |
EP3554493A1 (en) | 2019-10-23 |
US20180207119A1 (en) | 2018-07-26 |
CA3046558A1 (en) | 2018-06-28 |
MX2019007352A (es) | 2019-09-05 |
CU20190057A7 (es) | 2020-02-04 |
MA50763A (fr) | 2019-10-23 |
CL2019001685A1 (es) | 2019-08-30 |
ZA201903581B (en) | 2020-12-23 |
JP2020502183A (ja) | 2020-01-23 |
TWI780096B (zh) | 2022-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP19043725A (es) | Composiciones de aminoácidos y métodos para el tratamiento de enfermedades y trastornos musculares | |
CO2019006291A2 (es) | Composiciones de aminoácidos y métodos de tratamiento de enfermedades hepáticas | |
ECSP20011578A (es) | Composiciones de aminoácidos para el tratamiento de enfermedad hepática | |
DOP2019000005A (es) | 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostéricos de shp2 | |
CY1121826T1 (el) | Προφαρμακα καρβιντοπας και l-ντοπας και η χρηση τους στην αγωγη της νοσου parkinson | |
EA201790398A1 (ru) | Способы лечения заболевания печени | |
ZA202001057B (en) | Inhibiting ubiquitin specific peptidase 30 | |
DOP2016000109A (es) | Formas sólidas de ácido {[5-(3-clorofenil) -3-hidroxipiridin-2-carbonil] amino} acético, composiciones, y usos de las mismas. | |
BR112016009889A2 (pt) | ?compostos agonistas duplos gip-glp-1 e métodos? | |
AR109514A1 (es) | Análogos de amilina | |
AR115585A1 (es) | Composiciones y métodos para el tratamiento de la infiltración de grasa en músculo | |
CL2020001495A1 (es) | Composiciones y método para el tratamiento de enfermedades metabólicas | |
MX2018005628A (es) | Tratamientos de grasa acumulada con acido desoxicolico y sales del mismo. | |
CO2017007874A2 (es) | Composiciones y métodos para metabolismo muscular mejorado | |
EA201691567A1 (ru) | Способы лечения легких травм головного мозга | |
BR112018069682A2 (pt) | métodos de tratamento para doenças colestáticas e fibróticas | |
UY35328A (es) | Tratamiento de formas progresivas de esclerosis múltiple con laquinimod | |
MX2020004397A (es) | Uso de suplementos de aminoacidos para mejorar la sintesis de proteinas musculares. | |
PH12017501304A1 (en) | Levodopa and carbidopa intestinal gel and method of use | |
EA201791154A1 (ru) | Лечение болезней и нарушений аналогами кальцитонина | |
MX2022014577A (es) | Gel intestinal de levodopa y carbidopa y metodos de uso. | |
EA201991504A1 (ru) | Композиции на основе аминокислот и способы лечения заболеваний и нарушений мышц | |
NZ705229A (en) | Pharmaceutical formulations containing ipidacrine and their use for the treatment of disorders of potency and disorders of other forms of sexual activity | |
EA201991502A1 (ru) | Композиции на основе аминокислот и способы лечения заболеваний печени | |
AR103448A1 (es) | Gel intestinal de levodopa y carbidopa y métodos de uso |